Valuation models
price $473.19 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused472.63 – 847.73619.1824% undervaluedDCF · Perpetuity growth · 10y530.30 – 930.28686.7231% undervaluedDCF · EBITDA exit · 5y749.21 – 834.37790.6340% undervaluedDCF · EBITDA exit · 10y756.07 – 918.31833.2943% undervaluedP/E · peers270.46 – 926.47646.0527% undervaluedP/E · own history381.67 – 506.15438.468% overvaluedPEG—303.8856% overvaluedEV/EBITDA · peers179.92 – 1,501.86313.1251% overvaluedEV/Revenue · peers—11.643965% overvaluedDividend discount53.06 – 113.0576.45519% overvaluedWall St. consensus target—495.004% belowCost of capital (WACC)—7.58%—
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
619.18
HCA Healthcare closed at $473.19 — undervalued by 24% vs model.
472.63the model's range847.73
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
11.64 – 833.29
Wall St. target
495.00 4% below
Below model, 1y
30 of 30 days
How it is valued
Valued asMature & Stable
Low/slowing growth (~8% recent)Moderate margins (9% net margin)Highly cyclical earningsHigh leverage (D/E 5.0x)Strong FCF yield (7.5%)
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.